Clinical Trials on 蛋白激酶抑制剂 in United States
总计3118个结果
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Amgen主动,不招人
-
Thomas Jefferson UniversityJanssen Scientific Affairs, LLC主动,不招人
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)撤销
-
Fox Chase Cancer Center完全的
-
Dana-Farber Cancer InstituteNovartis; Millennium Pharmaceuticals, Inc.终止
-
Ohio State University Comprehensive Cancer CenterMerck Sharp & Dohme LLC完全的
-
Dana-Farber Cancer InstituteAmgen完全的
-
Children's Hospital of Orange CountyCSL Behring完全的
-
Dana-Farber Cancer InstituteBristol-Myers Squibb不再可用
-
Attaya SuvannasankhaNational Cancer Institute (NCI)终止
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital; Celgene Corporation终止
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)未知
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center完全的
-
Masonic Cancer Center, University of Minnesota完全的
-
M.D. Anderson Cancer CenterDaiichi Sankyo UK Ltd.终止
-
Sidney Kimmel Comprehensive Cancer Center at Johns...MedImmune LLC完全的
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.完全的
-
Emory UniversityMillennium Pharmaceuticals, Inc.终止
-
Washington University School of MedicinePaula C. & Rodger O. Riney Blood Cancer Research尚未招聘
-
Wake Forest University Health SciencesGlaxoSmithKline; Amgen主动,不招人
-
University of Michigan Rogel Cancer CenterGlaxoSmithKline主动,不招人
-
Spectrum Health Hospitals完全的
-
University of Arkansas完全的